Metabolic effects and drug interactions provoked by certain substances of plant origin: Grapefruit, St. John's Wort and garlic;Effets métaboliques et interactions médicamenteuses provoqués par certaines substances d'origine végétale: Pamplemousse, millepertuis et ail

Presse Medicale

Volumn 31, Issue 30, 2002, Pages 1416-1422

  Neuman, Maur ^a  

^a NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTIOXIDANT; ASCORBIC ACID; ASTEMIZOLE; ATORVASTATIN; AURANTIIN; CERIVASTATIN; CISAPRIDE; CLARITHROMYCIN; CYCLOSPORIN; CYTOCHROME P450 3A4; ERYTHROMYCIN; FLUOXETINE; GARLIC EXTRACT; GLYCOPROTEIN P; HYPERICUM PERFORATUM EXTRACT; ITRACONAZOLE; KETOCONAZOLE; LOSARTAN; LYCOPENE; MEVINOLIN; MIDAZOLAM; PECTIN; SAQUINAVIR; SILDENAFIL; SIMVASTATIN; TACROLIMUS; TRIAZOLAM; UNINDEXED DRUG; VINCA ALKALOID;

ANTIMICROBIAL ACTIVITY; DEPRESSION; DERMATITIS; DIURETIC ACTIVITY; DRUG BIOAVAILABILITY; DRUG METABOLISM; FIRST PASS EFFECT; FLOWER; FOOD DRUG INTERACTION; GARLIC; GRAPEFRUIT JUICE; HERBAL MEDICINE; HOMEOPATHY; HUMAN; HYPERICUM PERFORATUM; INTESTINE CELL; NEUROPSYCHIATRY; PHOTOSENSITIVITY DISORDER; REVIEW; RHEUMATOLOGY;

BEVERAGES; BIOLOGICAL AVAILABILITY; BIOTRANSFORMATION; CITRUS; CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; GARLIC; HERB-DRUG INTERACTIONS; HUMANS; HYPERICUM; MIXED FUNCTION OXYGENASES; PHYTOTHERAPY; SUBSTANCE P;

EID: 0037152118     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Bailey D, Malcolm J, Arnold O, Spencer D. Grapefruit juice-drug interactions. Br J Clin Pharmacol 1998; 46: 101-10.
2. Fuhr M. Drug interactions with Grapefruit Juice. Drug Safety 1998; 4: 251-72.
3. Piscitelli SC,Gallicano K. Interactions among drugs for HIV and opportunistic infections. N Engl J Med 2001; 13: 984-96.
4. Ameer B, Weintraub A. Drug interactions with grapefruit Juice. Clin Pharmacokin 1997; 2: 103-21.
5. Lundahl J, Regardh C, Edgar B, Johnsson G. Effects of grapefruit juice ingestion, pharmacokinetics and haemodynamics of I.V. and orally administered felodipine in healthy man. Br J Clin Pharmacol 1997; 52: 139-45.
6. Eagling V, Profit L, Back D. The effect of grapefruit juice constituents on the CYP 3A4 mediated metabolism and Pglycoprotein mediated transport of saquinavir. Br J Clin Pharmacol 1999; 47: 593.
7. James JS. Grapefruit juice and saquinavir. AIDS treatment News 1995; 235: 5-6.
8. Fuhr V, Kummert AL. The fate of naringin in humans: a key to grapefruit juice-drug interactions? Clin Pharmacol Ther 1995; 58: 365-73.
9. Edwards DJ, Bellevue FH, Woster PM. Identification of 6′7′-dihydroxy-bergamotin, a cytochrome P 450, in grapefruit juice. Drug Metab Dispos 1996; 24: 1287-90.
10. Lundahl J, Regardh C, Edgar B, Johnsson G. Relationship between time of intake of grapefruit juice and its effect on pharmakinetics and pharmacodynamics of felodipine. Eur J Clin Pharmacol 1995; 49: 61-7.
11. Schmiedlin-Ren P, Edwards DJ, Fitzsimmons M et al. Mechanisms of enhanced oral availability of CYP 3A4 substrates by grapefruit juice constituent: decreased CYP 3A4 concentration and mechanism based inactivation by furanocoumarins. Drug Metab Dispos 1997; 25: 1228-33
12. Uno T, Ohkubo T, Sugawara K, Higashiyama A. Effect of grapefruit juice on the disposition of nicardipine after administration of intravenous and oral doses. Clin Pharmacol Ther 1997; 61: 209.
13. Fukuda K, Ohta T, Oshima Y et al. Specific inhibitors in grapefruit juice: furanocoumarin dimers as components of drug interaction Pharmacogenetics 1997; 3: 391-6.
14. Fuhr V, Harder S, Lopez-Rojas et al. Increase of verapamil concentrations in steady state by co-administration of grapefruit juice. Naunyn-Schmiedebergs Arch Pharmacol 1994; 349(Suppl): R 134.
15. Ducharme M, Warbasse L, Edwards D. Disposition of intravenous and oral ciclosporin after administration with grapefruit juice. Clin Pharmacol Ther 1995; 57: 318-24.
16. Bailey DG, Spence JD, Munoz C, Arnold JM. Interaction of citrus juice with felodipine and nifedipine. Lancet 1991; 337: 268-9.
17. Kupferschmid H, Ziegler W, Meir P, Krahenbuhl S. Interaction between grapefruit juice and midazolam in humans. Clin Pharmacol 1989; 36: 89-96.
18. Hukkinen S, Varhe A, Olkkola K, Neuvonen P. Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice. Clin Pharmacol Ther 1995; 58: 127-33.
19. Hollander A, van Rooij J, Lentjes EG et al. The effect of grapefruit juice on ciclosporin and prednisone metabolism in transplant patients. Clin Pharmacol Ther 1995; 57: 318-24.
20. Vincent J, Foulds G, Dogolo LC, Willavize SA. Grapefruit juice does not alter the pharmacokinctics of amlodipine in man. Clin Pharmacokin Ther 1997; 61: 233.
21. Ran S, Bend JR, Arnold JM, Trau L et al. Grapefruit juiceterfenadine single dose interaction, magnitude, mechanism and relevance. Clin Pharmacol Ther 1997; 61: 401-9.
22. Min Di, Ku Y-M, Geraets DR, Lee HC. Effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of quinidine in healthy volunteers. J Clin Pharmacol 1996; 36: 469-76.
23. Fuhr V, Maier A, Keller A et al. Lacking effect of grapefruit juice on theophylline pharmacokinetics. Int J Clin Pharmacol Ther 1995; 33: 311-14.
24. Sigush H, Henschel L, Kraul H et al. Lack of effect of grapefruit juice on diltiazem bioavailability in normal subjects. Pharmacie 1994; 49: 675-9.
25. Weber A, Jager R, Borner A et al. Can grapefruit juice influence ethinylestradiol bio-availability. Contraception 1996; 53: 41-7.
26. Zaidenstein R et al. Effect of grapefruit juice on the bis pharmacokinetics of losartan and its active metabolite E3174 in healthy volunteers. Therapeutic Drug Monitoring 2001; 23: 369-73.
27. DeSilva KE, Le Flore DB, Marstan BJ, Rimland D. Serotonin ter syndrome in HIV-infected individuals receiving antiretrorival therapy and fluoxetine AIDS 2001; 15: 1281-5.
28. Roby CA, Anderson GD, Kantor E, Dryer DA, Burstein AH. St. John's wort: effect on CYP 3A4 activity. Clin Pharmacol Ther 2000; 67: 451-7.
29. Piscitelli SC, Burstein AH, Chairr D, Alfaro RM, Fallon J. Indinavir concentrations and St. John's wort. Lancet 2000; 355: 547-8.
30. Johne A, Brockmoller J, Bauer S, Maurer A et al. Pharmacokinetic interaction of digoxin with a herbal extract from St. John's wort. Clin Pharmacol Ther 1999; 66: 338-45.
31. Linde K, Ramirez G, Muirow CD et al. St. John's wort for depression: an overview and meta analysis of randomised clinical trials. BMJ 1996; 313: 253-8.
32. Karilova M, Treichel V, Malago M, Frilling A et al. Interaction of hypericum perforatum with ciclosporin A metabolism in a patient after liver transplantation. J Hepatol 2000; 33: 853-5.
33. Gand K, Ganjoo TN. Antibacterial principle of Hypericum perforatum. Int J Pharm 1999; 21: 172-5.
34. Gurevich AI, Dobrynin VN, Kolosov MN etal. Hyperforin, an antibiotic from Hypericum perforatum. Antibiotiki 1971; 16: 510-13.
35. Biber A, Fisher H, Römer A, Charterjee S. Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers. Pharmacopsychiatry 1998; 31(Suppl 1): 36-43.
36. Schenepp Ch, Pelz K, Witmer A et al. Antibacterial activity of hyperforin from St. John's wort against multiresistant staphylococcus aureus and Gram-positive bacteria. Lancet 1999; 353: 2129.
37. Foster BC, Gallicano K, Cameron W, Choudhri SH. Constituents of garlic inhibit cytochrome P450 3A4 mediated metabolism. Can J Infect Dis 1998; 9(suppl.A4/2P): abstract.
38. Dalvi RR. Alterations in hepatic phase I and phase II biotransformation enzymes by garlic oil in rats. Toxicol Lett 1992; 60: 299-305.
39. Laroche M, Choudhri S, Gallicano K, Foster B. Severe gastrointestinal toxicity with concomitant ingestion of ritonavir and garlic. Can J Infect Dis 1998; 9(Suppl.A-47 1P): abstract.